Drug Comparison

PillID

Pill Identifier Drug Encyclopedia Drug Classes Interactions Blog 🌙

Lipitor vs Crestor: Key Differences

Lipitor (atorvastatin) and Crestor (rosuvastatin) are both high-intensity statins used to lower LDL cholesterol and reduce the risk of cardiovascular events. They share the same fundamental mechanism and both have robust clinical trial data supporting their use, yet they differ in potency, drug interaction profile, and certain safety considerations. Choosing between them often comes down to individual patient factors rather than a clear-cut winner.

Quick Comparison

Feature	Lipitor (Atorvastatin)	Crestor (Rosuvastatin)
Drug Class	HMG-CoA Reductase Inhibitor (Statin)	HMG-CoA Reductase Inhibitor (Statin)
Brand Names	Lipitor	Crestor
Half-Life	~14 hours	~19 hours
DEA Schedule	None	None
Pregnancy	Category X — contraindicated	Category X — contraindicated
Best For	LDL reduction, cardiovascular risk reduction; widely available generic	Maximum LDL reduction; preferred for patients on multiple medications due to fewer CYP3A4 interactions

How They're Similar

Both atorvastatin and rosuvastatin competitively inhibit HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. By blocking this enzyme, they reduce intracellular cholesterol in the liver, which upregulates LDL receptors and increases clearance of LDL from the bloodstream. The net result is a significant reduction in LDL cholesterol, total cholesterol, and triglycerides, with a modest increase in HDL cholesterol.

Both drugs are classified as high-intensity statins, meaning at their approved doses they reduce LDL by 50% or more. Both are taken once daily, are contraindicated in pregnancy, and carry a class risk of myopathy (muscle injury) that can — rarely — progress to life-threatening rhabdomyolysis. Neither is a controlled substance, and both are indicated for primary and secondary cardiovascular prevention.

Key Differences

Potency and LDL Reduction

Rosuvastatin is the most potent statin currently available on a milligram-for-milligram basis. It achieves the highest percentage LDL reductions of any statin. Atorvastatin is also a high-intensity statin with comparable efficacy at higher doses, but rosuvastatin generally achieves greater LDL reduction at equivalent or lower doses.

Drug Interactions

Atorvastatin is primarily metabolized by the CYP3A4 enzyme system. This creates clinically significant interactions with CYP3A4 inhibitors — including certain macrolide antibiotics (erythromycin, clarithromycin), azole antifungals (itraconazole, ketoconazole), protease inhibitors used in HIV treatment, and grapefruit juice. These interactions can substantially raise atorvastatin blood levels and increase the risk of myopathy. Rosuvastatin is metabolized mainly by CYP2C9, with a different interaction profile. It is not meaningfully affected by CYP3A4 inhibitors, making it a preferred choice for patients on complex polypharmacy regimens.

Cardiovascular Outcome Trials

Both drugs have landmark outcome trial data. Atorvastatin demonstrated benefits in the ASCOT-LLA trial (primary prevention in hypertensive patients) and the TNT trial (secondary prevention comparing intensive vs. moderate LDL lowering). Rosuvastatin was the subject of the JUPITER trial (primary prevention in patients with elevated CRP) and the SATURN trial (comparing atorvastatin and rosuvastatin head-to-head for coronary atheroma regression). Both drugs have demonstrated reductions in cardiovascular events, cardiovascular mortality, and total mortality.

Diabetes Risk

All statins carry a small, class-wide risk of increasing blood glucose and new-onset type 2 diabetes. Some analyses from clinical trials have suggested a marginally higher incidence of new-onset diabetes with rosuvastatin compared to atorvastatin, though the absolute risk difference is small and the cardiovascular benefits of statin therapy overwhelmingly outweigh this risk in appropriate patients.

Lipitor (Atorvastatin): Strengths & Weaknesses

Strengths

• Generically available at very low cost
• Extensive long-term clinical trial data accumulated over decades
• High-intensity statin with robust LDL-lowering efficacy
• Once-daily dosing; can be taken at any time of day

Weaknesses

• CYP3A4 metabolism creates many clinically significant drug interactions
• Slightly less potent mg-for-mg than rosuvastatin
• Interaction with grapefruit juice requires dietary counseling

Crestor (Rosuvastatin): Strengths & Weaknesses

Strengths

• Most potent LDL-lowering statin available
• Fewer CYP3A4-based drug interactions — preferred in polypharmacy settings
• Longer half-life may offer slight flexibility in missed doses
• No grapefruit interaction

Weaknesses

• Still under patent for some formulations; may be more expensive than generic atorvastatin
• Marginally higher observed rate of new-onset diabetes in some trial analyses
• Dose adjustment required in severe renal impairment and in Asian patients (higher plasma levels observed)

Which Is Right for You?

For most patients requiring high-intensity statin therapy, both atorvastatin and rosuvastatin are excellent options. Atorvastatin's generic availability and cost make it a practical first choice in many settings. Rosuvastatin is preferred when maximum LDL reduction is needed or when CYP3A4-based drug interactions are a concern. Asian patients may require lower starting doses of rosuvastatin due to higher plasma concentrations observed in this population.

Frequently Asked Questions